Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology.
about
Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Overcoming disease-specific ma ...... luidic immunoassay technology.
@en
Overcoming disease-specific ma ...... luidic immunoassay technology.
@nl
type
label
Overcoming disease-specific ma ...... luidic immunoassay technology.
@en
Overcoming disease-specific ma ...... luidic immunoassay technology.
@nl
prefLabel
Overcoming disease-specific ma ...... luidic immunoassay technology.
@en
Overcoming disease-specific ma ...... luidic immunoassay technology.
@nl
P2093
P2860
P356
P1433
P1476
Overcoming disease-specific ma ...... luidic immunoassay technology.
@en
P2093
Kathi Williams
Rich Erickson
Saloumeh Kadkhodayan Fischer
P2860
P304
P356
10.4155/BIO-2017-0102
P577
2017-08-02T00:00:00Z